The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door

Francesco Talotta1,2, Laura Casalino1, Pasquale Verde3

  • 1Institute of Genetics and Biophysics "Adriano Buzzati Traverso" CNR, Naples, Italy.

Oncogene
|May 10, 2020
PubMed

Insights

The transcription factor Fra-1 (encoded by FOSL1) drives human tumor progression and metastasis. This review explores FOSL1

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Fra-1 (FOSL1) is a key transcription factor in the AP-1 complex implicated in human cancer.
  • Understanding Fra-1's role is critical for developing targeted cancer therapies.

Purpose of the Study:

  • To provide a comprehensive review of the current knowledge on FOSL1 and its gene product, Fra-1.
  • To discuss emerging topics, therapeutic strategies, and Fra-1's role in cancer progression and treatment resistance.

Main Methods:

  • Literature review summarizing existing research on FOSL1.
  • Analysis of transcriptional, epigenetic, and post-translational regulation of Fra-1.
  • Examination of Fra-1's role in gene networks, tumor microenvironment, and therapeutic resistance.

Main Results:

  • FOSL1 controls Fra-1 accumulation through transcriptional and epigenetic mechanisms in various solid tumors.
  • Fra-1 influences proliferation, survival, epithelial-mesenchymal transitions (EMT), and the tumor microenvironment.
  • Fra-1 signatures have prognostic value and Fra-1 is involved in resistance and addiction to targeted therapies.

Conclusions:

  • Fra-1 is a significant driver of tumor progression, metastasis, and therapeutic resistance.
  • Targeting FOSL1 presents a promising therapeutic avenue for various human cancers.
  • Further research into Fra-1 regulation and function is warranted for effective cancer treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.0K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.2K